<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jah38661" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="pmc-domain-id">1888</journal-id><journal-id journal-id-type="pmc-domain">jaha</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10492953</article-id><article-id pub-id-type="pmcid-ver">PMC10492953.1</article-id><article-id pub-id-type="pmcaid">10492953</article-id><article-id pub-id-type="pmcaiid">10492953</article-id><article-id pub-id-type="pmid">37548171</article-id><article-id pub-id-type="doi">10.1161/JAHA.123.029963</article-id><article-id pub-id-type="publisher-id">JAH38661</article-id><article-id pub-id-type="other">JAHA/2023/029963</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></subj-group></article-categories><title-group><article-title>Revisiting the Smoking Paradox in Acute Ischemic Stroke Patients: Findings From the Chinese Stroke Center Alliance Study</article-title><alt-title alt-title-type="right-running-head">Smoking Paradox in Patients With Acute Ischemic Stroke</alt-title><alt-title alt-title-type="left-running-head">Hu et al</alt-title></title-group><contrib-group><contrib id="jah38661-cr-0001" contrib-type="author"><name name-style="western"><surname>Hu</surname><given-names initials="G">Guoliang</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9453-5393</contrib-id><xref rid="jah38661-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah38661-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="jah38661-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jah38661-cr-0002" contrib-type="author"><name name-style="western"><surname>Gu</surname><given-names initials="H">Hongqiu</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1608-1856</contrib-id><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38661-cr-0003" contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="Y">Yingyu</given-names></name><degrees>MHS</degrees><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38661-cr-0004" contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="X">Xin</given-names></name><degrees>MD</degrees><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38661-cr-0005" contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="Y">Yong</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7700-6054</contrib-id><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38661-cr-0006" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="C">Chunjuan</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1627-5004</contrib-id><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38661-cr-0007" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zixiao</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4713-5418</contrib-id><xref rid="jah38661-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah38661-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="jah38661-cr-0008" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yongjun</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9976-2341</contrib-id><xref rid="jah38661-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah38661-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="jah38661-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jah38661-cr-0009" contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yilong</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2725-2788</contrib-id><xref rid="jah38661-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah38661-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah38661-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="jah38661-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="jah38661-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>yilong528@aliyun.com</email></address></contrib></contrib-group><aff id="jah38661-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology, Beijing Tiantan Hospital</named-content>
<institution>Capital Medical University</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jah38661-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>China National Clinical Research Center for Neurological Diseases</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jah38661-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Advanced Innovation Center for Human Brain Protection</named-content>
<institution>Capital Medical University</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jah38661-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>National Center for Neurological Diseases</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jah38661-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Chinese Institute for Brain Research</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Correspondence to: Yilong Wang, MD, PhD, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China. Email: <email>yilong528@aliyun.com</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>15</day><month>8</month><year>2023</year></pub-date><volume>12</volume><issue seq="140">16</issue><issue-id pub-id-type="pmc-issue-id">445039</issue-id><issue-id pub-id-type="doi">10.1002/jah3.v12.16</issue-id><elocation-id>e029963</elocation-id><history><date date-type="received"><day>23</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>16</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>11</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-11 00:25:09.683"><day>11</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JAH3-12-e029963.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JAH3-12-e029963.pdf"/><abstract><sec id="jah38661-sec-0001"><title>Background</title><p>Smoking is a well&#8208;established risk factor for the development of acute ischemic stroke (AIS). However, the &#8220;smoker's paradox&#8221; suggests that it is associated with favorable clinical outcomes following stroke. We aimed to reevaluate the association between smoking and in&#8208;hospital outcomes in patients with AIS in contemporary practice.</p></sec><sec id="jah38661-sec-0002"><title>Methods and Results</title><p>A total of 649&#8201;610 inpatients with AIS from 1476 participating hospitals in the Chinese Stroke Center Alliance were included. In&#8208;hospital outcomes measurement included all&#8208;cause mortality, discharge against medical advice, and complications. Multivariable logistic regression models adjusting for baseline characteristics, clinical profiles at presentation, and in&#8208;hospital management were used to evaluate the association between smoking and in&#8208;hospital outcomes. A propensity score&#8211;matched analysis was also conducted. Of these patients with AIS, 36.8% (n=238&#8201;912) were smokers. Smokers were younger, had fewer comorbidities, and had slightly lower rates of adverse in&#8208;hospital outcomes than nonsmokers (all&#8208;cause death or discharge against medical advice: 6.0% versus 6.1%; in&#8208;hospital complications: 14.5% versus 15.1%). Multivariable analysis revealed that smoking was associated with higher risk of adverse in&#8208;hospital outcomes (all&#8208;cause death or discharge against medical advice: odds ratio [OR], 1.05 [95% CI, 1.02&#8211;1.08]; <italic toggle="no">P</italic>&lt;0.001; complications: OR, 1.06 [95% CI, 1.04&#8211;1.08]; <italic toggle="no">P</italic>&lt;0.001). The excess risk of adverse in&#8208;hospital outcomes remained in smoking patients with AIS after propensity score&#8208;matching analysis (all&#8208;cause death or discharge against medical advice: OR, 1.04 [95% CI, 1.00&#8211;1.08]; <italic toggle="no">P</italic>=0.034; complications: OR, 1.05 [95% CI, 1.03&#8211;1.08]; <italic toggle="no">P</italic>&lt;0.001).</p></sec><sec id="jah38661-sec-0003"><title>Conclusions</title><p>Smoking was associated with increased risk of adverse in&#8208;hospital outcomes among patients with AIS in contemporary practice, reinforcing the importance of smoking cessation in patients with AIS.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah38661-kwd-0001">acute ischemic stroke</kwd><kwd id="jah38661-kwd-0002">in&#8208;hospital outcomes</kwd><kwd id="jah38661-kwd-0003">smoke</kwd><kwd id="jah38661-kwd-0004">smoking paradox</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Risk Factors</kwd><kwd>Ischemic Stroke</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>81825007</award-id></award-group><award-group id="funding-0002"><funding-source>Beijing Outstanding Young Scientist Program</funding-source><award-id>BJJWZYJH01201910025030</award-id></award-group><award-group id="funding-0003"><funding-source>Youth Beijing Scholar Program</funding-source><award-id>010</award-id></award-group><award-group id="funding-0004"><funding-source>Beijing Talent Project &#8208; Class A: Innovation and Development</funding-source><award-id>2018A12</award-id></award-group><award-group id="funding-0005"><funding-source>&#8220;National Ten&#8208;Thousand Talent Plan&#8221;&#8208;Leadership of Scientific and Technological Innovation</funding-source></award-group><award-group id="funding-0006"><funding-source>National Key R&amp;D Program of China</funding-source><award-id>2017YFC1310901</award-id><award-id>2017YFC1307905</award-id><award-id>2017YFC1307900</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="25"/><word-count count="5204"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>15 August 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.3 mode:remove_FC converted:21.08.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jah38661-ntgp-0001"><fn id="jah38661-note-0001"><p>This article was sent to Luciano A. Sposato, MD, MBA, FRCPC, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p></fn><fn id="jah38661-note-0002"><p>Supplemental Material is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.029963" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.029963</ext-link>
</p></fn><fn id="jah38661-note-0003"><p>For Sources of Funding and Disclosures, see page 10.</p></fn></fn-group></notes></front><body id="jah38661-body-0001"><def-list list-content="abbreviations" id="jah38661-lp-0001"><title>Nonstandard Abbreviations and Acronyms</title><def-item><term id="jah38661-li-0001">AIS</term><def id="jah38661-li-0002"><p>acute ischemic stroke</p></def></def-item><def-item><term id="jah38661-li-0003">ASD</term><def id="jah38661-li-0004"><p>absolute standardized difference</p></def></def-item><def-item><term id="jah38661-li-0005">CSCA</term><def id="jah38661-li-0006"><p>Chinese Stroke Center Alliance</p></def></def-item><def-item><term id="jah38661-li-0007">DAMA</term><def id="jah38661-li-0008"><p>discharge against medical advice</p></def></def-item><def-item><term id="jah38661-li-0009">NIHSS</term><def id="jah38661-li-0010"><p>National Institutes of Health Stroke Scale</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="jah38661-blkfxd-0001" orientation="portrait"><caption><title>Clinical Perspective</title></caption><sec id="jah38661-sec-0006"><title>What Is New?</title><p>
<list list-type="bullet" id="jah38661-list-0001"><list-item id="jah38661-li-0011"><p>The present study is the largest contemporary study that evaluated the smoking paradox on in&#8208;hospital outcomes of patients with acute ischemic stroke in China.</p></list-item><list-item id="jah38661-li-0012"><p>Smokers hospitalized for acute ischemic stroke were younger, had fewer cardiovascular risk factors, received acute treatments for secondary prevention more frequently, and had lower rates of in&#8208;hospital mortality and in&#8208;hospital complications than nonsmokers.</p></list-item><list-item id="jah38661-li-0013"><p>The observed association of the smoking paradox with in&#8208;hospital outcomes was mainly attributable to younger age, better clinical conditions, and more evidence&#8208;based acute treatments provided to smokers with acute ischemic stroke.</p></list-item></list>
</p></sec><sec id="jah38661-sec-0007"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah38661-list-0002"><list-item id="jah38661-li-0014"><p>It is necessary and essential to encourage smoking cessation as a primary prevention or secondary prevention strategy in real clinical practice.</p></list-item><list-item id="jah38661-li-0015"><p>Implementation of formal smoking treatment pathways for patients with acute ischemic stroke should be a priority for clinical practice in China.</p></list-item></list>
</p></sec></boxed-text>
</p><p>Stroke has been the leading cause of death and disability&#8208;adjusted life&#8208;year in China, causing an enormous health care and economic burden.<xref rid="jah38661-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="jah38661-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> There were 28.76&#8201;million patients with stroke nationwide in 2019, including 24.18&#8201;million patients with ischemic stroke and 1.03&#8201;million deaths from ischemic stroke.<xref rid="jah38661-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="jah38661-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> It has been become particularly important to develop and implement more effective strategies and actions to reduce the stroke burden.</p><p>Smoking is a globally well&#8208;established and preventable risk factor for the development of acute ischemic stroke (AIS). Interestingly, previous studies have suggested existence of a &#8220;smoker's paradox,&#8221; meaning smokers with AIS had favorable or similar clinical outcomes than nonsmokers,<xref rid="jah38661-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="jah38661-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> which was in conflict with the general notion that smoking is detrimental to patient health. The paradox was first seen in patients post myocardial infarction but later with ischemic stroke.<xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah38661-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="jah38661-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> To date, the association between smoking and in&#8208;hospital outcomes among patients with AIS remains controversial and the principal mechanism underlying the smoker's paradox continues to be debated. Most likely there are differences in confounding factors adjusted in multivariable analysis model, definition of in&#8208;hospital outcomes, and length of in&#8208;hospital stay of inpatients. However, such confusing data could have negative public health impacts and limited the effectiveness of secondary prevention to some extent. Indeed, more than one &#8208;third of smokers believed that the risks of smoking are greatly exaggerated.<xref rid="jah38661-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> It is, therefore, essential to clarify this issue by further observational study among patients with AIS.</p><p>We hypothesize that the smoking paradox could be related to confounding factors and inadequate definition of in&#8208;hospital outcomes in patients with AIS. In the present study, we therefore aimed to reevaluate the association between smoking and in&#8208;hospital outcomes among patients with AIS based on the Chinese Stroke Center Alliance (CSCA) program, a nationwide quality improvement initiative for stroke.</p><sec sec-type="methods" id="jah38661-sec-0008"><title>Methods</title><p>The data sets analyzed during the current study are not publicly available due to intellectual property rights but are available from the corresponding author on reasonable request.</p><sec id="jah38661-sec-0009"><title>Study Design</title><p>The CSCA, modeled after the American Heart Association's Get With the Guidelines&#8211;Stroke program, is a large, national, hospital&#8208;based, voluntary, and continuous quality&#8208;improvement study. The program was made available to all secondary and tertiary hospitals across 31 provinces, autonomous regions, and municipalities in China. Details of the design and methodology of the CSCA project have been published.<xref rid="jah38661-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Trained hospital personnel in each participating hospital used a web&#8208;based electronic case report form (Medicine Innovation Research Center, Beijing, China) to collect patients' clinical data. The China National Clinical Research Center for Neurological Diseases served as the data analysis center under an agreement to analyze the aggregate deidentified data for care quality feedback and research purposes. The CSCA program was approved by the ethics committee of Beijing Tiantan Hospital. Each participating hospital had the approval from the local institutional review board to enroll participants without requiring individual informed consent under the Common Rule or a waiver of authorization and exemption because only deidentified data were collected from routine clinical practice.</p></sec><sec id="jah38661-sec-0010"><title>Study Population</title><p>The CSCA program consecutively enrolled patients aged over 18&#8201;years with a primary diagnosis of acute stroke or transient ischemic attack confirmed by brain computed tomography or magnetic resonance imaging within 7&#8201;days of symptom onset from secondary or tertiary hospitals between August 2015 and July 2019 from 1476 participating hospitals across China. Of the 1&#8201;006&#8201;798 initially recruited inpatients, 649&#8201;610 were analyzed in this study after excluding patients with transient ischemic attack, hemorrhagic stroke, subarachnoid hemorrhage, diagnosed as &#8220;undetermined&#8221;, or those with missing data of death and discharge against medical advice (DAMA). The flow chart of patient inclusion in the current study is presented in Figure&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S1</xref>. We compared the baseline characteristics of those with and without missing data of death and DAMA, and most of the variables were largely comparable between the 2 groups (Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S1</xref>).</p></sec><sec id="jah38661-sec-0011"><title>Study Variables</title><sec id="jah38661-sec-0012"><title>Smoking Status</title><p>Information on smoking status was abstracted from patients' medical records by trained abstractors. The study population was divided into 2 groups based on their smoking status, including smokers and nonsmokers. Smokers were defined as people who had smoked before the current hospitalization episode, including current smokers and former smokers. Nonsmokers were defined as people who had never smoked in their lifetime.</p></sec></sec><sec id="jah38661-sec-0013"><title>In&#8208;Hospital Outcomes</title><p>The primary outcomes investigated in this study referred to in&#8208;hospital all&#8208;cause mortality and DAMA, were recorded in medical records by physicians. DAMA is common for many inpatients withdraw from treatment at unfavorable or terminal status because of the reluctance of many patients to die in hospital in China. The Chinese Government uses in&#8208;hospital mortality or DAMA as a quality measure for hospitals.<xref rid="jah38661-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="jah38661-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> The secondary outcome was in&#8208;hospital complications, including recurrent ischemic stroke, recurrent hemorrhagic stroke, myocardial infarction, cardiac or respiratory arrest, pneumonia, pulmonary embolism, and gastrointestinal bleeding. Detailed definitions of other variables are provided in Data&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S1</xref>.</p></sec><sec id="jah38661-sec-0014"><title>Statistical Analysis</title><p>Continuous variables were described as mean (SD) for normally distributed data and median (interquartile range) for skewed data. Categorical variables were presented as the number (percentage). Patients' baseline characteristics, in&#8208;hospital management, and in&#8208;hospital outcomes were compared using absolute standardized differences (ASD). An ASD of &gt;10 is considered clinically significant.<xref rid="jah38661-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Logistic regression analyses were carried out to examine the association between smoking and in&#8208;hospital outcomes. Univariable analysis was performed first, followed by multivariable&#8208;adjusted analysis. The confounding factors adjusted in the multivariable model included baseline characteristics, risk factors, medical history, in&#8208;hospital management, and stroke severity. To account for missing values on National Institutes of Health Stroke Scale (NIHSS) score, we performed multiple imputation with chained equations by using 10 iterations to impute missing values of NIHSS score, and the risk of smoking was recalculated in model 3 adjusting the imputed NIHSS score. Odds ratios (ORs) with 95% CIs are reported.</p><p>Because former smokers were classified as smokers in our study, who could benefit from quitting smoking and associated with better clinical outcomes, we conducted a sensitivity analysis by excluding these patients from smokers and recalculated the risk of smoking.</p><p>Subgroup analyses, including age, sex, hypertension, diabetes, and in&#8208;hospital NIHSS score, were performed using multivariable logistic regression model. The ORs between the analyzed subgroups were compared by a <italic toggle="yes">Z</italic> test.</p><p>We further conducted a propensity score&#8208;matched analysis to confirm the association between smoking and in&#8208;hospital outcomes. First, a propensity score for smoking was calculated by using a logistic regression model with the following variables: age, sex, body mass index, hypertension, diabetes, dyslipidemia, drinking, history of stroke/transient ischemic attack, history of myocardial infarction, history of atrial fibrillation, history of heart failure, history of carotid stenosis, history of peripheral artery disease, history of liver/renal dysfunction, in&#8208;hospital NIHSS score, education level, insurance, hospital level, and location. Patients with and without smoking were then matched at 1:1 according to the propensity scores using nearest&#8208;neighbor matching without replacement, with a caliper size of 0.02. The ASDs of variables included for the calculation of propensity score were compared before and after propensity score matching (Figure&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S2</xref>). Standardized differences &lt;10.0% for these included variables indicated successful balancing between groups. The baseline characteristics and in&#8208;hospital management between the 2 propensity&#8208;score&#8208;matched groups were recompared. The in&#8208;hospital outcomes are presented as number (percentage) and are compared using ASD. Univariable logistic regression analysis was performed to calculate ORs and 95% CIs.</p><p>Statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). Two&#8208;tailed <italic toggle="yes">P</italic>&lt;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="jah38661-sec-0015"><title>Results</title><sec id="jah38661-sec-0016"><title>Characteristics of the Study Population</title><p>We identified a total of 649&#8201;610 inpatients with AIS, of whom 238&#8201;912 (36.8%) were smokers (current smokers: 153276 [23.6%]; former smokers: 85636 [13.2%]). Mean age was observed to be 66.2&#177;12.0&#8201;years; 62.6% of patients were male. Smokers were younger than nonsmokers, with a difference of 4.3&#8201;years between the mean age of smokers (63.5&#8201;years) and nonsmokers (67.8&#8201;years; Table&#160;<xref rid="jah38661-tbl-0001" ref-type="table">1</xref>). Compared with nonsmokers, smokers were less likely to have hypertension (86.8% versus 88.1%) and diabetes (30.9% versus 35.3%) but more often had a history of stroke/transient ischemic attack (31.9% versus 30.9%), myocardial infarction (2.0% versus 1.5%), and peripheral artery disease (1.9% versus 1.6%).</p><table-wrap position="float" id="jah38661-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Baseline Characteristics of Patients With Acute Ischemic Stroke</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Total (N=649&#8201;610)</th><th align="left" rowspan="1" colspan="1">Smokers (N=238&#8201;912)</th><th align="left" rowspan="1" colspan="1">Nonsmokers (N=410&#8201;698)</th><th align="left" rowspan="1" colspan="1">ASD (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y, mean (SD)</td><td align="left" rowspan="1" colspan="1">66.2 (12.0)</td><td align="left" rowspan="1" colspan="1">63.5 (11.8)</td><td align="left" rowspan="1" colspan="1">67.8 (11.9)</td><td align="left" rowspan="1" colspan="1">36.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Women, n (%)</td><td align="left" rowspan="1" colspan="1">243&#8201;079 (37.4)</td><td align="left" rowspan="1" colspan="1">10&#8201;555 (4.4)</td><td align="left" rowspan="1" colspan="1">232&#8201;524 (56.6)</td><td align="left" rowspan="1" colspan="1">137.6</td></tr><tr><td align="left" colspan="5" rowspan="1">Education, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">College</td><td align="left" rowspan="1" colspan="1">18&#8201;588 (2.9)</td><td align="left" rowspan="1" colspan="1">8401 (3.5)</td><td align="left" rowspan="1" colspan="1">10&#8201;187 (2.5)</td><td align="left" rowspan="1" colspan="1">5.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">High school</td><td align="left" rowspan="1" colspan="1">193&#8201;200 (29.7)</td><td align="left" rowspan="1" colspan="1">83&#8201;239 (34.8)</td><td align="left" rowspan="1" colspan="1">109&#8201;961 (26.8)</td><td align="left" rowspan="1" colspan="1">17.4</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Below elementary</td><td align="left" rowspan="1" colspan="1">192&#8201;343 (29.6)</td><td align="left" rowspan="1" colspan="1">59&#8201;247 (24.8)</td><td align="left" rowspan="1" colspan="1">133&#8201;096 (32.4)</td><td align="left" rowspan="1" colspan="1">16.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Unclear</td><td align="left" rowspan="1" colspan="1">245&#8201;479 (37.8)</td><td align="left" rowspan="1" colspan="1">88&#8201;025 (36.8)</td><td align="left" rowspan="1" colspan="1">157&#8201;454 (38.3)</td><td align="left" rowspan="1" colspan="1">3.1</td></tr><tr><td align="left" colspan="5" rowspan="1">Insurance, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Urban employee basic medical insurance</td><td align="left" rowspan="1" colspan="1">184&#8201;654 (28.4)</td><td align="left" rowspan="1" colspan="1">75&#8201;006 (31.4)</td><td align="left" rowspan="1" colspan="1">109&#8201;648 (26.7)</td><td align="left" rowspan="1" colspan="1">10.4</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Urban resident basic medical insurance</td><td align="left" rowspan="1" colspan="1">134&#8201;151 (20.7)</td><td align="left" rowspan="1" colspan="1">45&#8201;181 (18.9)</td><td align="left" rowspan="1" colspan="1">88&#8201;970 (21.7)</td><td align="left" rowspan="1" colspan="1">7.0</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">New rural cooperative medical scheme</td><td align="left" rowspan="1" colspan="1">263&#8201;735 (40.6)</td><td align="left" rowspan="1" colspan="1">92&#8201;683 (38.8)</td><td align="left" rowspan="1" colspan="1">171&#8201;052 (41.6)</td><td align="left" rowspan="1" colspan="1">5.7</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Self&#8208;pay</td><td align="left" rowspan="1" colspan="1">39&#8201;543 (6.1)</td><td align="left" rowspan="1" colspan="1">15&#8201;891 (6.7)</td><td align="left" rowspan="1" colspan="1">23&#8201;652 (5.8)</td><td align="left" rowspan="1" colspan="1">3.7</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Others</td><td align="left" rowspan="1" colspan="1">27&#8201;527 (4.2)</td><td align="left" rowspan="1" colspan="1">10&#8201;151 (4.2)</td><td align="left" rowspan="1" colspan="1">17&#8201;376 (4.2)</td><td align="left" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI<xref rid="jah38661-note-0005" ref-type="table-fn">*</xref>, kg/m<sup>2</sup>, mean (SD)</td><td align="left" rowspan="1" colspan="1">24.0 (4.3)</td><td align="left" rowspan="1" colspan="1">24.1 (4.3)</td><td align="left" rowspan="1" colspan="1">23.9 (4.3)</td><td align="left" rowspan="1" colspan="1">4.7</td></tr><tr><td align="left" colspan="5" rowspan="1">BMI<xref rid="jah38661-note-0005" ref-type="table-fn">*</xref>, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&lt;24.0</td><td align="left" rowspan="1" colspan="1">350&#8201;772 (54.4)</td><td align="left" rowspan="1" colspan="1">125&#8201;415 (52.8)</td><td align="left" rowspan="1" colspan="1">225&#8201;357 (55.3)</td><td align="left" rowspan="1" colspan="1">5.0</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">24.0&#8804;BMI&lt;28.0</td><td align="left" rowspan="1" colspan="1">239&#8201;471 (37.1)</td><td align="left" rowspan="1" colspan="1">93&#8201;280 (39.3)</td><td align="left" rowspan="1" colspan="1">146&#8201;191 (35.9)</td><td align="left" rowspan="1" colspan="1">7.0</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#8805;28.0</td><td align="left" rowspan="1" colspan="1">54&#8201;644 (8.5)</td><td align="left" rowspan="1" colspan="1">18&#8201;732 (7.9)</td><td align="left" rowspan="1" colspan="1">35&#8201;912 (8.8)</td><td align="left" rowspan="1" colspan="1">3.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP<xref rid="jah38661-note-0006" ref-type="table-fn">&#8224;</xref>, mm Hg, mean (SD)</td><td align="left" rowspan="1" colspan="1">150.0 (23.0)</td><td align="left" rowspan="1" colspan="1">149.3 (22.6)</td><td align="left" rowspan="1" colspan="1">150.5 (23.2)</td><td align="left" rowspan="1" colspan="1">5.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic BP<xref rid="jah38661-note-0007" ref-type="table-fn">&#8225;</xref>, mm Hg, mean (SD)</td><td align="left" rowspan="1" colspan="1">87.0 (13.9)</td><td align="left" rowspan="1" colspan="1">87.9 (14.0)</td><td align="left" rowspan="1" colspan="1">86.5 (13.8)</td><td align="left" rowspan="1" colspan="1">10.1</td></tr><tr><td align="left" colspan="5" rowspan="1">Risk factors</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="left" rowspan="1" colspan="1">569&#8201;085 (87.6)</td><td align="left" rowspan="1" colspan="1">207&#8201;352 (86.8)</td><td align="left" rowspan="1" colspan="1">361&#8201;733 (88.1)</td><td align="left" rowspan="1" colspan="1">3.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Diabetes, n (%)</td><td align="left" rowspan="1" colspan="1">218&#8201;967 (33.7)</td><td align="left" rowspan="1" colspan="1">73&#8201;865 (30.9)</td><td align="left" rowspan="1" colspan="1">145&#8201;102 (35.3)</td><td align="left" rowspan="1" colspan="1">9.4</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Dyslipidemia, n (%)</td><td align="left" rowspan="1" colspan="1">101&#8201;844 (15.7)</td><td align="left" rowspan="1" colspan="1">39&#8201;625 (16.6)</td><td align="left" rowspan="1" colspan="1">62&#8201;219 (15.1)</td><td align="left" rowspan="1" colspan="1">4.1</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Drinking, n (%)</td><td align="left" rowspan="1" colspan="1">150&#8201;933 (23.2)</td><td align="left" rowspan="1" colspan="1">124&#8201;965 (52.3)</td><td align="left" rowspan="1" colspan="1">25&#8201;968 (6.3)</td><td align="left" rowspan="1" colspan="1">117.1</td></tr><tr><td align="left" colspan="5" rowspan="1">History of diseases</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Stroke/transient ischemic attack, n (%)</td><td align="left" rowspan="1" colspan="1">203&#8201;109 (31.3)</td><td align="left" rowspan="1" colspan="1">76&#8201;129 (31.9)</td><td align="left" rowspan="1" colspan="1">126&#8201;980 (30.9)</td><td align="left" rowspan="1" colspan="1">2.2</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Myocardial infarction, n (%)</td><td align="left" rowspan="1" colspan="1">10&#8201;998 (1.7)</td><td align="left" rowspan="1" colspan="1">4701 (2.0)</td><td align="left" rowspan="1" colspan="1">6297 (1.5)</td><td align="left" rowspan="1" colspan="1">3.8</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Atrial fibrillation, n (%)</td><td align="left" rowspan="1" colspan="1">34&#8201;264 (5.3)</td><td align="left" rowspan="1" colspan="1">9026 (3.8)</td><td align="left" rowspan="1" colspan="1">25&#8201;238 (6.1)</td><td align="left" rowspan="1" colspan="1">10.6</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Heart failure, n (%)</td><td align="left" rowspan="1" colspan="1">6978 (1.1)</td><td align="left" rowspan="1" colspan="1">2231 (0.9)</td><td align="left" rowspan="1" colspan="1">4747 (1.2)</td><td align="left" rowspan="1" colspan="1">2.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Carotid stenosis, n (%)</td><td align="left" rowspan="1" colspan="1">8143 (1.3)</td><td align="left" rowspan="1" colspan="1">3709 (1.6)</td><td align="left" rowspan="1" colspan="1">4434 (1.1)</td><td align="left" rowspan="1" colspan="1">4.3</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Peripheral artery disease, n (%)</td><td align="left" rowspan="1" colspan="1">11&#8201;157 (1.7)</td><td align="left" rowspan="1" colspan="1">4543 (1.9)</td><td align="left" rowspan="1" colspan="1">6614 (1.6)</td><td align="left" rowspan="1" colspan="1">2.3</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Liver/renal dysfunction, n (%)</td><td align="left" rowspan="1" colspan="1">6495 (1.0)</td><td align="left" rowspan="1" colspan="1">2622 (1.1)</td><td align="left" rowspan="1" colspan="1">3873 (0.9)</td><td align="left" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">NIHSS<xref rid="jah38661-note-0008" ref-type="table-fn">&#167;</xref>, mean (SD)</td><td align="left" rowspan="1" colspan="1">4.9 (5.4)</td><td align="left" rowspan="1" colspan="1">4.6 (5.0)</td><td align="left" rowspan="1" colspan="1">5.0 (5.5)</td><td align="left" rowspan="1" colspan="1">7.6</td></tr><tr><td align="left" colspan="5" rowspan="1">NIHSS<xref rid="jah38661-note-0008" ref-type="table-fn">&#167;</xref>, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0&#8211;4</td><td align="left" rowspan="1" colspan="1">343&#8201;647 (64.6)</td><td align="left" rowspan="1" colspan="1">131&#8201;802 (66.0)</td><td align="left" rowspan="1" colspan="1">211&#8201;845 (63.8)</td><td align="left" rowspan="1" colspan="1">4.6</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">5&#8211;14</td><td align="left" rowspan="1" colspan="1">154&#8201;329 (29.0)</td><td align="left" rowspan="1" colspan="1">57&#8201;199 (28.7)</td><td align="left" rowspan="1" colspan="1">97&#8201;130 (29.3)</td><td align="left" rowspan="1" colspan="1">1.3</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#8805;15</td><td align="left" rowspan="1" colspan="1">33&#8201;603 (6.3)</td><td align="left" rowspan="1" colspan="1">10&#8201;607 (5.3)</td><td align="left" rowspan="1" colspan="1">22&#8201;996 (6.9)</td><td align="left" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" colspan="5" rowspan="1">Hospital region, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Eastern</td><td align="left" rowspan="1" colspan="1">297&#8201;346 (45.8)</td><td align="left" rowspan="1" colspan="1">109&#8201;718 (45.9)</td><td align="left" rowspan="1" colspan="1">187&#8201;628 (45.7)</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Central</td><td align="left" rowspan="1" colspan="1">218&#8201;150 (33.6)</td><td align="left" rowspan="1" colspan="1">78&#8201;967 (33.1)</td><td align="left" rowspan="1" colspan="1">139&#8201;183 (33.9)</td><td align="left" rowspan="1" colspan="1">1.7</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Western</td><td align="left" rowspan="1" colspan="1">134&#8201;114 (20.6)</td><td align="left" rowspan="1" colspan="1">50&#8201;227 (21.0)</td><td align="left" rowspan="1" colspan="1">83&#8201;887 (20.4)</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" colspan="5" rowspan="1">Hospital level, n (%)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Secondary</td><td align="left" rowspan="1" colspan="1">257&#8201;455 (39.6)</td><td align="left" rowspan="1" colspan="1">91&#8201;107 (38.1)</td><td align="left" rowspan="1" colspan="1">166&#8201;348 (40.5)</td><td align="left" rowspan="1" colspan="1">4.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Tertiary</td><td align="left" rowspan="1" colspan="1">392&#8201;155 (60.4)</td><td align="left" rowspan="1" colspan="1">147&#8201;805 (61.9)</td><td align="left" rowspan="1" colspan="1">244&#8201;350 (59.5)</td><td align="left" rowspan="1" colspan="1">4.9</td></tr></tbody></table><table-wrap-foot id="jah38661-ntgp-0002"><fn id="jah38661-note-0004"><p>ASD indicates absolute standard difference; BMI, body mass index; BP, blood pressure; and NIHSS, National Institutes of Health Stroke Scale.</p></fn><fn id="jah38661-note-0005"><label>*</label><p>BMI, data of BMI were not available for 4723 patients.</p></fn><fn id="jah38661-note-0006"><label>
<sup>&#8224;</sup>
</label><p>SBP, data of SBP were not available for 121 patients.</p></fn><fn id="jah38661-note-0007"><label>
<sup>&#8225;</sup>
</label><p>DBP, data of DBP were not available for 126 patients.</p></fn><fn id="jah38661-note-0008"><label>
<sup>&#167;</sup>
</label><p>NIHSS, data of NIHSS were not available for 118&#8201;040 patients.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah38661-sec-0017"><title>In&#8208;Hospital Management of Patients With <styled-content style="fixed-case" toggle="no">AIS</styled-content>
</title><p>We compared the in&#8208;hospital management for AIS between patients with and without smoking (Table&#160;<xref rid="jah38661-tbl-0002" ref-type="table">2</xref>). Smokers were more likely to receive in&#8208;hospital treatments than nonsmokers, including intravenous tissue plasminogen activator, antiplatelet therapy, and statins. The length of stay was comparable between patients with and without smoking in this study.</p><table-wrap position="float" id="jah38661-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>In&#8208;Hospital Management of Patients With Acute Ischemic Stroke</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Total (N=649&#8201;610)</th><th align="left" rowspan="1" colspan="1">Smokers (N=238&#8201;912)</th><th align="left" rowspan="1" colspan="1">Nonsmokers (N=410&#8201;698)</th><th align="left" rowspan="1" colspan="1">ASD (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Intravenous recombinant tissue plasminogen activator administration &#8804;4.5&#8201;h, n (%)</td><td align="left" rowspan="1" colspan="1">38&#8201;782 (6.1)</td><td align="left" rowspan="1" colspan="1">15&#8201;086 (6.4)</td><td align="left" rowspan="1" colspan="1">23&#8201;696 (5.9)</td><td align="left" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiplatelet drugs, n (%)</td><td align="left" rowspan="1" colspan="1">532&#8201;767 (83.6)</td><td align="left" rowspan="1" colspan="1">199&#8201;251 (84.9)</td><td align="left" rowspan="1" colspan="1">333&#8201;516 (82.9)</td><td align="left" rowspan="1" colspan="1">5.4</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Aspirin</td><td align="left" rowspan="1" colspan="1">471&#8201;523 (74.0)</td><td align="left" rowspan="1" colspan="1">178&#8201;621 (76.1)</td><td align="left" rowspan="1" colspan="1">292&#8201;902 (72.8)</td><td align="left" rowspan="1" colspan="1">7.6</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Clopidogrel</td><td align="left" rowspan="1" colspan="1">308&#8201;025 (48.3)</td><td align="left" rowspan="1" colspan="1">120&#8201;038 (51.1)</td><td align="left" rowspan="1" colspan="1">187&#8201;987 (46.7)</td><td align="left" rowspan="1" colspan="1">8.8</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Aspirin+clopidogrel</td><td align="left" rowspan="1" colspan="1">250&#8201;886 (39.4)</td><td align="left" rowspan="1" colspan="1">100&#8201;636 (42.9)</td><td align="left" rowspan="1" colspan="1">150&#8201;250 (37.3)</td><td align="left" rowspan="1" colspan="1">11.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Anticoagulant, n (%)</td><td align="left" rowspan="1" colspan="1">33&#8201;941 (5.3)</td><td align="left" rowspan="1" colspan="1">11&#8201;235 (4.8)</td><td align="left" rowspan="1" colspan="1">22&#8201;706 (5.6)</td><td align="left" rowspan="1" colspan="1">3.6</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Unfractionated heparin</td><td align="left" rowspan="1" colspan="1">3237 (0.5)</td><td align="left" rowspan="1" colspan="1">1039 (0.4)</td><td align="left" rowspan="1" colspan="1">2198 (0.5)</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Low&#8208;molecular&#8208;weight heparin</td><td align="left" rowspan="1" colspan="1">23&#8201;546 (3.7)</td><td align="left" rowspan="1" colspan="1">8166 (3.5)</td><td align="left" rowspan="1" colspan="1">15&#8201;380 (3.8)</td><td align="left" rowspan="1" colspan="1">1.6</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Warfarin</td><td align="left" rowspan="1" colspan="1">7011 (1.1)</td><td align="left" rowspan="1" colspan="1">2091 (0.9)</td><td align="left" rowspan="1" colspan="1">4920 (1.2)</td><td align="left" rowspan="1" colspan="1">2.9</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Other anticoagulants</td><td align="left" rowspan="1" colspan="1">3762 (0.6)</td><td align="left" rowspan="1" colspan="1">1155 (0.5)</td><td align="left" rowspan="1" colspan="1">2607 (0.6)</td><td align="left" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Statins, n (%)</td><td align="left" rowspan="1" colspan="1">51&#8201;647 (8.0)</td><td align="left" rowspan="1" colspan="1">19&#8201;670 (8.2)</td><td align="left" rowspan="1" colspan="1">31&#8201;977 (7.8)</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Rehabilitation, n (%)</td><td align="left" rowspan="1" colspan="1">481&#8201;569 (74.1)</td><td align="left" rowspan="1" colspan="1">176&#8201;701 (74.0)</td><td align="left" rowspan="1" colspan="1">304&#8201;868 (74.2)</td><td align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay<xref rid="jah38661-note-0010" ref-type="table-fn">*</xref>, median (interquartile range), d</td><td align="left" rowspan="1" colspan="1">11.0 (8.0&#8211;14.0)</td><td align="left" rowspan="1" colspan="1">11.0 (8.0&#8211;14.0)</td><td align="left" rowspan="1" colspan="1">11.0 (8.0&#8211;14.0)</td><td align="left" rowspan="1" colspan="1">1.5</td></tr></tbody></table><table-wrap-foot id="jah38661-ntgp-0003"><fn id="jah38661-note-0009"><p>AIS indicates acute ischemic stroke; ASD, absolute standard difference; and IV&#8208;rtPA, intravenous recombinant tissue plasminogen activator.</p></fn><fn id="jah38661-note-0010"><label>*</label><p>Length of stay, data of length of stay were not available for 890 patients.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah38661-sec-0018"><title>Association Between Smoking and In&#8208;Hospital Outcomes</title><p>Smokers had a slight lower rate of in&#8208;hospital outcomes than nonsmokers (all&#8208;cause death or DAMA: 6.0% versus 6.1%, in&#8208;hospital complications: 14.5% versus 15.1%; Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S2</xref>). In univariable analysis, smoking was associated with lower unadjusted OR for in&#8208;hospital all&#8208;cause mortality or DAMA of 0.97 (95% CI, 0.95&#8211;0.99, <italic toggle="yes">P</italic>=0.004) and in&#8208;hospital complications of 0.96 (95% CI, 0.94&#8211;0.97, <italic toggle="yes">P</italic>&lt;0.001), especially for all&#8208;cause mortality (OR, 0.74 [95% CI, 0.69&#8211;0.79], <italic toggle="yes">P</italic>&lt;0.001). However, after adjusting for confounding factors, the odds of experiencing the in&#8208;hospital outcomes investigated was &gt;1 for patients with AIS (all&#8208;cause death or DAMA: OR, 1.06 [95% CI, 1.03&#8211;1.09]; <italic toggle="yes">P</italic>&lt;0.001; in&#8208;hospital complications: OR, 1.07 [95% CI, 1.05&#8211;1.09]; <italic toggle="yes">P</italic>&lt;0.001). After further adjusting in&#8208;hospital NIHSS score, the higher risk of poor in&#8208;hospital outcomes was still statistically significant in patients with smoking (all&#8208;cause death or DAMA: OR, 1.05 [95% CI, 1.01&#8211;1.08]; <italic toggle="yes">P</italic>=0.004; in&#8208;hospital complications: OR, 1.07 [95% CI, 1.05&#8211;1.09]; <italic toggle="yes">P</italic>&lt;0.001). Moreover, after multiple imputation with chained equations being used to impute missing value of in&#8208;hospital NIHSS score, the significant association between smoking and poor in&#8208;hospital outcomes (all&#8208;cause death or DAMA: OR, 1.05 [95% CI, 1.02&#8211;1.08]; <italic toggle="yes">P</italic>&lt;0.001; in&#8208;hospital complications: OR, 1.06 [95% CI, 1.04&#8211;1.08]; <italic toggle="yes">P</italic>&lt;0.001) still remained in patients with AIS after multivariable adjustment (Table&#160;<xref rid="jah38661-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="jah38661-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Association Between Smoking and In&#8208;Hospital Outcomes in Patients With Acute Ischemic Stroke</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" rowspan="1" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Unadjusted</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Adjusted: model 1</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Adjusted: model 2</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Adjusted: model 3</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Unadjusted OR (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th><th align="left" rowspan="1" colspan="1">Adjusted OR (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th><th align="left" rowspan="1" colspan="1">Adjusted OR (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th><th align="left" rowspan="1" colspan="1">Adjusted OR (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">All&#8208;cause death or DAMA</td><td align="left" rowspan="1" colspan="1">0.97 (0.95&#8211;0.99)</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">1.06 (1.03&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.05 (1.01&#8211;1.08)</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">1.05 (1.02&#8211;1.08)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">All&#8208;cause death</td><td align="left" rowspan="1" colspan="1">0.74 (0.69&#8211;0.79)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.00 (0.91&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">0.921</td><td align="left" rowspan="1" colspan="1">0.97 (0.87&#8211;1.07)</td><td align="left" rowspan="1" colspan="1">0.508</td><td align="left" rowspan="1" colspan="1">0.96 (0.87&#8211;1.05)</td><td align="left" rowspan="1" colspan="1">0.388</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">DAMA</td><td align="left" rowspan="1" colspan="1">1.00 (0.97&#8211;1.02)</td><td align="left" rowspan="1" colspan="1">0.695</td><td align="left" rowspan="1" colspan="1">1.06 (1.03&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.05 (1.02&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">1.06 (1.03&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">In&#8208;hospital complications</td><td align="left" rowspan="1" colspan="1">0.96 (0.94&#8211;0.97)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.07 (1.05&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.07 (1.05&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.06 (1.04, 1.08)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Recurrent ischemic stroke</td><td align="left" rowspan="1" colspan="1">1.02 (0.99&#8211;1.04)</td><td align="left" rowspan="1" colspan="1">0.187</td><td align="left" rowspan="1" colspan="1">0.97 (0.94&#8211;1.00)</td><td align="left" rowspan="1" colspan="1">0.073</td><td align="left" rowspan="1" colspan="1">0.98 (0.95&#8211;1.01)</td><td align="left" rowspan="1" colspan="1">0.212</td><td align="left" rowspan="1" colspan="1">0.97 (0.94, 1.00)</td><td align="left" rowspan="1" colspan="1">0.059</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Recurrent hemorrhagic stroke</td><td align="left" rowspan="1" colspan="1">0.87 (0.82&#8211;0.91)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">0.98 (0.91&#8211;1.05)</td><td align="left" rowspan="1" colspan="1">0.531</td><td align="left" rowspan="1" colspan="1">0.97 (0.90&#8211;1.05)</td><td align="left" rowspan="1" colspan="1">0.452</td><td align="left" rowspan="1" colspan="1">0.97 (0.90, 1.04)</td><td align="left" rowspan="1" colspan="1">0.365</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="left" rowspan="1" colspan="1">1.05 (0.97&#8211;1.14)</td><td align="left" rowspan="1" colspan="1">0.214</td><td align="left" rowspan="1" colspan="1">1.00 (0.90&#8211;1.10)</td><td align="left" rowspan="1" colspan="1">0.924</td><td align="left" rowspan="1" colspan="1">1.01 (0.90&#8211;1.14)</td><td align="left" rowspan="1" colspan="1">0.829</td><td align="left" rowspan="1" colspan="1">0.99 (0.89, 1.10)</td><td align="left" rowspan="1" colspan="1">0.817</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Gastrointestinal bleeding</td><td align="left" rowspan="1" colspan="1">1.00 (0.95&#8211;1.05)</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">1.11 (1.04&#8211;1.19)</td><td align="left" rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1">1.07 (0.99&#8211;1.15)</td><td align="left" rowspan="1" colspan="1">0.091</td><td align="left" rowspan="1" colspan="1">1.10 (1.03, 1.18)</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Pneumonia</td><td align="left" rowspan="1" colspan="1">0.94 (0.92&#8211;0.96)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.13 (1.10&#8211;1.15)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.14 (1.11&#8211;1.17)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">1.12 (1.09, 1.15)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Pulmonary embolism</td><td align="left" rowspan="1" colspan="1">0.92 (0.83&#8211;1.03)</td><td align="left" rowspan="1" colspan="1">0.132</td><td align="left" rowspan="1" colspan="1">0.88 (0.77&#8211;1.02)</td><td align="left" rowspan="1" colspan="1">0.081</td><td align="left" rowspan="1" colspan="1">0.81 (0.69&#8211;0.94)</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.88 (0.76, 1.01)</td><td align="left" rowspan="1" colspan="1">0.075</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Cardiac or respiratory arrest</td><td align="left" rowspan="1" colspan="1">0.81 (0.75&#8211;0.88)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td><td align="left" rowspan="1" colspan="1">0.98 (0.88&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">0.680</td><td align="left" rowspan="1" colspan="1">0.96 (0.85&#8211;1.09)</td><td align="left" rowspan="1" colspan="1">0.531</td><td align="left" rowspan="1" colspan="1">0.95 (0.85, 1.06)</td><td align="left" rowspan="1" colspan="1">0.337</td></tr></tbody></table><table-wrap-foot id="jah38661-ntgp-0004"><fn id="jah38661-note-0011"><p>Model 1: age, sex, body mass index, hypertension, diabetes, dyslipidemia, drinking, history of stroke/transient ischemic attack, history of carotid stenosis, history of myocardial infarction, history of atrial fibrillation, history of heart failure, history of peripheral artery disease, history of liver/renal dysfunction, administration of antiplatelet agent use, administration of anticoagulant therapy and administration of statins, rehabilitation, education, insurance, hospital region and level.</p><p>Model 2: adjusted for variables in model 1 plus in&#8208;hospital National Institutes of Health Stroke Scale score.</p><p>Model 3: adjusted for variables in model 1 plus imputed in&#8208;hospital National Institutes of Health Stroke Scale score. DAMA indicates discharge against medical advice; and OR, odds ratio.</p></fn></table-wrap-foot></table-wrap><p>We then conducted a sensitivity analysis to evaluate the association between smoking and in&#8208;hospital outcomes (Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S3</xref>). After excluding former smokers who quitting smoking before the current stroke (n=85&#8201;636) in patients with smoking, current smokers were still significantly associated with an increased risk of poor in&#8208;hospital outcomes (OR, 1.13 [95% CI, 1.09&#8211;1.17]; <italic toggle="yes">P</italic>&lt;0.001).</p><p>Subgroup analyses were performed based on important baseline characteristics. Higher risks of poor in&#8208;hospital outcomes and complications were observed in patients with smoking in most subgroups. (Figures&#160;<xref rid="jah38661-fig-0001" ref-type="fig">1</xref> and <xref rid="jah38661-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="Figure" id="jah38661-fig-0001" orientation="portrait"><label>Figure 1</label><caption><title>Subgroup analysis for the association between smoking and in&#8208;hospital mortality and DAMA in patients with AIS.</title><p>AIS indicates acute ischemic stroke; DAMA, discharge against medical advice; NIHSS, National Institutes of Health Stroke Scale; and OR, odds ratio.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JAH3-12-e029963-g001.jpg"/></fig><fig position="float" fig-type="Figure" id="jah38661-fig-0002" orientation="portrait"><label>Figure 2</label><caption><title>Subgroup analysis for the association between smoking and in&#8208;hospital complications in patients with AIS.</title><p>AIS indicates acute ischemic stroke; NIHSS, National Institutes of Health Stroke Scale; and OR, odds ratio.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="JAH3-12-e029963-g002.jpg"/></fig></sec><sec id="jah38661-sec-0019"><title>Propensity Score&#8208;Matching Analysis</title><p>In propensity score matching, 114&#8201;131 patients with AIS who smoked were matched with 114&#8201;131 patients without smoking. After matching, the ASDs were &lt;10.0% for all variables included for the calculation of propensity score, indicating that patients with AIS with and without smoking were well matched. The baseline characteristics and in&#8208;hospital management between these 2 groups were recompared, whereby all of the characteristics were comparable (Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S4</xref>). The rate of poor in&#8208;hospital outcomes was higher in patients with smoking compared with those without smoking (all&#8208;cause death or DAMA: 6.0% versus 5.8%; in&#8208;hospital complications: 15.0% versus 14.4%) (Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S2</xref>), and an excess risk of in&#8208;hospital outcomes independently associated with smoking was also found (all&#8208;cause death or DAMA: OR, 1.04 [95% CI, 1.00&#8211;1.08]; <italic toggle="yes">P</italic>=0.034; in&#8208;hospital complications: OR, 1.05 [95% CI, 1.03&#8211;1.08]; <italic toggle="yes">P</italic>&lt;0.001; Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S5</xref>).</p></sec></sec><sec sec-type="discussion" id="jah38661-sec-0020"><title>Discussion</title><p>This study is the largest contemporary hospital&#8208;based study to evaluate the association between smoking and in&#8208;hospital outcomes among patients with AIS. Our findings showed that smoking was significantly associated with higher risk of poor in&#8208;hospital outcomes among patients with AIS, which provides direct evidence of the health risks of smoking.</p><p>Consistent with previous reports, we observed a lower unadjusted in&#8208;hospital outcomes rate in smoker than nonsmokers among patients with AIS.<xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Similar to those in previous studies, smokers in the present study were younger and had fewer comorbidities, including hypertension, diabetes, and atrial fibrillation, than nonsmokers.<xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah38661-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="jah38661-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> After adjustment for confounding factors, smoking was significantly associated with increased risk of poor in&#8208;hospital outcomes among patients with AIS. Further propensity score matching confirmed the association between smoking and adverse in&#8208;hospital outcomes. However, some studies have reported opposing results.<xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah38661-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> A study conducted among 4305 patients with AIS showed that smoking was independently associated with lower all&#8208;cause in&#8208;hospital mortality (OR, 0.64 [95% CI, 0.42&#8211;0.96]; <italic toggle="yes">P</italic>=0.03) in patients with AIS.<xref rid="jah38661-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Although this study used prehospital factors, including demographics, medical history and preadmission medications, and severity of stroke for adjustment, information concerning in&#8208;hospital treatments and complications were not considered. Similarly, a recent report from Get With the Guidelines involving 899&#8201;295 patients with AIS demonstrated that smoking was associated with lower risk of in&#8208;hospital mortality (OR, 0.86 [95% CI, 0.83&#8211;0.89]) in patients with AIS without accounting for in&#8208;hospital medications.<xref rid="jah38661-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Our study clearly indicated that the paradoxical association between smoking and in&#8208;hospital outcomes after AIS was overturned after multivariable adjustments, and the statistical association still existed in the sensitivity analysis. Moreover, propensity score matching showed that smoking patients with AIS had a higher rate of adverse in&#8208;hospital outcomes than nonsmokers, suggesting the observed differences of adverse in&#8208;hospital outcomes between smokers and nonsmokers could be attributable to confounding covariates. Additionally, results from subgroup analysis showed that there were large differences in the association between smoking and in&#8208;hospital mortality and DAMA among patients with AIS by sex, in line with those from previous studies. A meta&#8208;analysis included 55 publications containing 141 cohort studies indicated that the relative risk of cardiovascular diseases for smoking seemed to be higher among women than men.<xref rid="jah38661-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> In China, the prevalence of smoking among women is much lower than that among men,<xref rid="jah38661-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="jah38661-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> which may lead to the neglect of the issue of smoking among women. Given the harmful effects of smoking on women, there is an urgent need to focus on smoking cessation interventions for the female population.</p><p>Moreover, smoking patients with AIS in our study are significantly younger than those who do not smoke, which further proves that smoking is an important risk factor for AIS. Although smokers had less other traditional cardiovascular risk factors, smoking could make the patients suffering from AIS 4.3&#8201;years earlier. In line with our study, a meta&#8208;analysis showed that the pooled mean difference of onset age between smoking and nonsmoking patients with AIS was &#8722;10.05 (&#8722;12.91 to &#8722;7.19), indicated that smoking causes first onset of AIS to occur 10&#8201;years earlier.<xref rid="jah38661-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> These findings highlight the importance of providing smoking cessation guidance for smoking patients in real clinical practice.</p><p>Furthermore, one point worth noting is that we took DAMA into account for our study outcomes, which was not considered in most of the previous studies. DAMA is common for many patients withdraw from treatment at unfavorable or terminal status in China, which could be attributed to culture or affordability.<xref rid="jah38661-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Therefore, a focus on in&#8208;hospital death alone, without accounting for these patients with DAMA, might underestimate the actual rate of acute phase death. In our study, univariable analysis showed smoking was significantly associated with lower risk of in&#8208;hospital mortality. After adjusting for confounding factors, we did not find that smoking has a direct association with in&#8208;hospital mortality among patients with AIS, suggesting smoking was not a protect factor for in&#8208;hospital death. Notably, when DAMA was included in the end point, the results were significant and the point estimate did suggest a detriment.</p><p>In terms of smoking paradox in the setting of long&#8208;term outcome following AIS, the results from currently available evidence are controversial.<xref rid="jah38661-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38661-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="jah38661-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="jah38661-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="jah38661-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> In a multicenter registry study of 1118 patients with stroke who received intravenous thrombolysis, smoking was associated with lower risk of mortality at 90&#8201;days (OR, 0.27 [95% CI, 0.13&#8211;0.58]; <italic toggle="yes">P</italic>=0.001) in patients with large artery atherosclerosis subtype.<xref rid="jah38661-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Nevertheless, a prospective study conducted among 1589 patients with stroke over 10&#8208;year of follow&#8208;up showed that current smokers (hazard ratio [HR], 1.42 [95% CI, 1.13&#8211;1.78]; <italic toggle="yes">P</italic>=0.003) and ex&#8208;smokers (HR, 1.18 [95% CI, 1.01&#8211;1.39]; <italic toggle="yes">P</italic>=0.039) at baseline had poorer outcome (death, acute myocardial infarction, or recurrent stroke) than those who had never smoked.<xref rid="jah38661-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Therefore, further studies with examination of smoking status and the risk of adverse clinical outcomes are warranted.</p><p>Our study is strengthened by the large sample size and the coverage of the Chinese population, as well as the careful study design, which provided a comprehensive assessment of in&#8208;hospital management of patients with AIS with sufficient information to evaluate the impact of potential confounders. However, our study has the following limitations. First, smoking data were abstracted from patients' medical records, and information about duration of smoking and number of cigarettes was unavailable. Therefore, we were unable to study the dose&#8211;response association of total smoking exposure with in&#8208;hospital outcomes. The limited information on smoking status also meant that we could not distinguish between those who had quit smoking soon before their stroke and those who had quit smoking much earlier. Second, we adjusted for some confounding factors in the regression model; nonetheless, the findings may have been affected by other residual measured and unmeasured confounding. Third, the CSCA project recruited only patients with AIS who were admitted to the hospital, and there was no information on patients who died outside of the hospital. This may have led to potential selection bias. Fourth, information about endovascular thrombectomy was not available, which future studies should take into consideration. Fifth, the limited information does not allow us to distinguish whether the patient was discharged due to withdrawal of treatment based on unfavorable prognosis or due to affordability. Sixth, as this was a real&#8208;world study for patients with AIS based on medical records, 90&#8208;day modified Rankin scale data were not available for our study. Finally, because &#8776;20% of patients were not included in the final analysis due to missing variables of outcome, selection bias cannot be completely ruled out. However, most baseline characteristics between patients with and without missing outcome variables were largely comparable (Table&#160;<xref rid="jah38661-supitem-0001" ref-type="supplementary-material">S1</xref>).</p></sec><sec sec-type="conclusions" id="jah38661-sec-0021"><title>Conclusions</title><p>In the present large&#8208;scale nationwide representative quality improvement initiative, smoking was independently associated with increased risk of adverse in&#8208;hospital outcomes among patients with AIS, reinforcing the importance of smoking cessation in patients receiving contemporary management for AIS. As such, it is necessary and essential to encourage smoking cessation as a primary prevention or secondary prevention in real clinical practice.</p></sec><sec id="jah38661-sec-0023"><title>Sources of Funding</title><p>This study was supported by grants from the National Natural Science Foundation of China (No. 81825007), Beijing Outstanding Young Scientist Program (No. BJJWZYJH01201910025030), Youth Beijing Scholar Program (No. 010), Beijing Talent Project &#8208; Class A: Innovation and Development (No. 2018A12), &#8220;National Ten&#8208;Thousand Talent Plan&#8221;&#8208;Leadership of Scientific and Technological Innovation, and National Key R&amp;D Program of China (No. 2017YFC1307900, 2017YFC1307905, 2017YFC1310901).</p></sec><sec id="jah38661-sec-0024"><title>Disclosures</title><p>None.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jah38661-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Data S1</p><p>Tables S1&#8211;S5</p><p>Figures S1&#8211;S2</p><p>Reference 25</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JAH3-12-e029963-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="jah38661-sec-0022"><title>Acknowledgments</title><p>We thank all participating hospitals for their contributions to the CSCA program. Guoliang Hu: conceptualization, methodology, writing original draft, writing&#8212;review and editing. Hongqiu Gu: data curation, software, writing&#8212;review and editing. Yingyu Jiang: software, data curation. Xin Yang: data curation, project administration. Yong Jiang: data curation, supervision. Chunjuan Wang: data curation, project administration. Zixiao Li: supervision, funding acquisition. Yongjun Wang: supervision. Yilong Wang: conceptualization, funding acquisition, supervision, writing&#8212;review and editing.</p></ack><ref-list content-type="cited-references" id="jah38661-bibl-0001"><title>REFERENCES</title><ref id="jah38661-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah38661-cit-0001"><string-name name-style="western"><surname>Zhou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, et al. <article-title>Mortality, morbidity, and risk factors in China and its provinces, 1990&#8211;2017: a systematic analysis for the Global Burden of Disease Study 2017</article-title>. <source>Lancet</source>. <year>2019</year>;<volume>394</volume>:<fpage>1145</fpage>&#8211;<lpage>1158</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(19)30427-1</pub-id><pub-id pub-id-type="pmid">31248666</pub-id><pub-id pub-id-type="pmcid">PMC6891889</pub-id></mixed-citation></ref><ref id="jah38661-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah38661-cit-0002"><string-name name-style="western"><surname>Ma</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Qian</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Vaughn</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>McMillin</surname><given-names>SE</given-names></string-name>, et al. <article-title>Temporal trend and attributable risk factors of stroke burden in China, 1990&#8211;2019: an analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet Public Health</source>. <year>2021</year>;<volume>6</volume>:<fpage>e897</fpage>&#8211;<lpage>e906</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2468-2667(21)00228-0</pub-id><pub-id pub-id-type="pmid">34838196</pub-id><pub-id pub-id-type="pmcid">PMC9047702</pub-id></mixed-citation></ref><ref id="jah38661-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah38661-cit-0003"><string-name name-style="western"><surname>Wang</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>ZX</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>HQ</given-names></string-name>, <string-name name-style="western"><surname>Zhai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>XQ</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>YL</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>CJ</given-names></string-name>, et al. <article-title>China stroke statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non&#8208;communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations</article-title>. <source>Stroke Vasc Neurol</source>. <year>2022</year>;<volume>7</volume>:<fpage>415</fpage>&#8211;<lpage>450</lpage>. doi: <pub-id pub-id-type="doi">10.1136/svn-2021-001374</pub-id><pub-id pub-id-type="pmid">35443985</pub-id><pub-id pub-id-type="pmcid">PMC9614174</pub-id></mixed-citation></ref><ref id="jah38661-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah38661-cit-0004"><string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>BZ</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>XJ</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Xiang</surname><given-names>RL</given-names></string-name>. <article-title>"Smoking paradox" is not true in patients with ischemic stroke: a systematic review and meta&#8208;analysis</article-title>. <source>J Neurol</source>. <year>2021</year>;<volume>268</volume>:<fpage>2042</fpage>&#8211;<lpage>2054</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-019-09596-3</pub-id><pub-id pub-id-type="pmid">31664548</pub-id><pub-id pub-id-type="pmcid">PMC8179908</pub-id></mixed-citation></ref><ref id="jah38661-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah38661-cit-0005"><string-name name-style="western"><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>ZN</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>. <article-title>Meta&#8208;analysis of the smoker's paradox in acute ischemic stroke patients receiving intravenous thrombolysis or endovascular treatment</article-title>. <source>Nicotine Tob Res</source>. <year>2019</year>;<volume>21</volume>:<fpage>1181</fpage>&#8211;<lpage>1188</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ntr/ntz094</pub-id><pub-id pub-id-type="pmid">31219582</pub-id></mixed-citation></ref><ref id="jah38661-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah38661-cit-0006"><string-name name-style="western"><surname>Tong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, et al. <article-title>Smoking&#8208;thrombolysis relationship depends on ischemic stroke subtype</article-title>. <source>Stroke</source>. <year>2016</year>;<volume>47</volume>:<fpage>1811</fpage>&#8211;<lpage>1816</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.116.013124</pub-id><pub-id pub-id-type="pmid">27222526</pub-id></mixed-citation></ref><ref id="jah38661-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah38661-cit-0007"><string-name name-style="western"><surname>Ali</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Reeves</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xian</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hernandez</surname><given-names>AF</given-names></string-name>, <string-name name-style="western"><surname>Bhatt</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>. <article-title>Smoking paradox in patients hospitalized with coronary artery disease or acute ischemic stroke: findings from Get With the Guidelines</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2015</year>;<volume>8</volume>:<fpage>S73</fpage>&#8211;<lpage>S80</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.114.001244</pub-id><pub-id pub-id-type="pmid">26515213</pub-id></mixed-citation></ref><ref id="jah38661-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah38661-cit-0008"><string-name name-style="western"><surname>Ali</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Bhatt</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>. <article-title>Paradoxical association of smoking with in&#8208;hospital mortality among patients admitted with acute ischemic stroke</article-title>. <source>J Am Heart Assoc</source>. <year>2013</year>;<volume>2</volume>:<elocation-id>e000171</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.113.000171</pub-id><pub-id pub-id-type="pmid">23782919</pub-id><pub-id pub-id-type="pmcid">PMC3698779</pub-id></mixed-citation></ref><ref id="jah38661-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah38661-cit-0009"><string-name name-style="western"><surname>Aune</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Roislien</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mathisen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Thelle</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Otterstad</surname><given-names>JE</given-names></string-name>. <article-title>The "smoker's paradox" in patients with acute coronary syndrome: a systematic review</article-title>. <source>BMC Med</source>. <year>2011</year>;<volume>9</volume>:<fpage>97</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1741-7015-9-97</pub-id><pub-id pub-id-type="pmid">21861870</pub-id><pub-id pub-id-type="pmcid">PMC3179733</pub-id></mixed-citation></ref><ref id="jah38661-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah38661-cit-0010"><string-name name-style="western"><surname>Hu</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SC</given-names><suffix>Jr</suffix></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ge</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Huo</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Hao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, et al. <article-title>Smoking and provision of smoking cessation interventions among inpatients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China&#8208;Acute Coronary Syndrome Project</article-title>. <source>Glob Heart</source>. <year>2020</year>;<volume>15</volume>:<fpage>72</fpage>. doi: <pub-id pub-id-type="doi">10.5334/gh.784</pub-id><pub-id pub-id-type="pmid">33150137</pub-id><pub-id pub-id-type="pmcid">PMC7583717</pub-id></mixed-citation></ref><ref id="jah38661-bib-0011"><label>11</label><mixed-citation publication-type="miscellaneous" id="jah38661-cit-0011"><collab collab-type="authors">Department of Health and Social Care (United Kingdom)</collab>
. <article-title>Hidden dangers highlighted in new smoking campaign</article-title>. <year>2012</year>. Accessed January 11, 2015. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.gov.uk/government/news/hidden-dangers-highlighted-in-new-smoking-campaign" ext-link-type="uri">https://www.gov.uk/government/news/hidden&#8208;dangers&#8208;highlighted&#8208;in&#8208;new&#8208;smoking&#8208;campaign</ext-link></mixed-citation></ref><ref id="jah38661-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah38661-cit-0012"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, et al. <article-title>Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings</article-title>. <source>Stroke Vasc Neurol</source>. <year>2018</year>;<volume>3</volume>:<fpage>256</fpage>&#8211;<lpage>262</lpage>. doi: <pub-id pub-id-type="doi">10.1136/svn-2018-000154</pub-id><pub-id pub-id-type="pmid">30637133</pub-id><pub-id pub-id-type="pmcid">PMC6312129</pub-id></mixed-citation></ref><ref id="jah38661-bib-0013"><label>13</label><mixed-citation publication-type="miscellaneous" id="jah38661-cit-0013"><article-title>Ministry of health of the people's republic of China. The qualification standard of tertiary general hospital (version 2011)</article-title>. <year>2011</year>. Accessed March 6, 2014. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.nhc.gov.cn/wjw/gfxwj/201304/0404f9cd71764ab29b2365e069cfbf2d.shtml" ext-link-type="uri">http://www.nhc.gov.cn/wjw/gfxwj/201304/0404f9cd71764ab29b2365e069cfbf2d.shtml</ext-link></mixed-citation></ref><ref id="jah38661-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="jah38661-cit-0014"><article-title>Ministry of health of the people's republic of China. The qualification standard of secondary general hospital (version 2012)</article-title>. <year>2012</year>. Accessed March 6, 2014. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.nhc.gov.cn/yzygj/s3586q/201201/b8dda05b1d23413c94150b5c17b5cc6f.shtml" ext-link-type="uri">http://www.nhc.gov.cn/yzygj/s3586q/201201/b8dda05b1d23413c94150b5c17b5cc6f.shtml</ext-link></mixed-citation></ref><ref id="jah38661-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jah38661-cit-0015"><string-name name-style="western"><surname>Austin</surname><given-names>PC</given-names></string-name>. <article-title>Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research</article-title>. <source>Commun Stat Simul Comput</source>. <year>2009</year>;<volume>38</volume>:<fpage>1228</fpage>&#8211;<lpage>1234</lpage>. doi: <pub-id pub-id-type="doi">10.1080/03610910902859574</pub-id></mixed-citation></ref><ref id="jah38661-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah38661-cit-0016"><string-name name-style="western"><surname>Weng</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>WY</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>YY</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>TI</given-names></string-name>. <article-title>The impact of smoking on the severity of acute ischemic stroke</article-title>. <source>J Neurol Sci</source>. <year>2011</year>;<volume>308</volume>:<fpage>94</fpage>&#8211;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jns.2011.05.046</pub-id><pub-id pub-id-type="pmid">21665225</pub-id></mixed-citation></ref><ref id="jah38661-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah38661-cit-0017"><string-name name-style="western"><surname>Bejot</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jacquin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Daubail</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lainay</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Janoura</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aboa&#8208;Eboule</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Durier</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Giroud</surname><given-names>M</given-names></string-name>. <article-title>Smoking status and severity of ischemic stroke. A population&#8208;based study</article-title>. <source>Eur Neurol</source>. <year>2014</year>;<volume>71</volume>:<fpage>59</fpage>&#8211;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000355021</pub-id><pub-id pub-id-type="pmid">24334964</pub-id></mixed-citation></ref><ref id="jah38661-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah38661-cit-0018"><string-name name-style="western"><surname>Hackshaw</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Boniface</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Milenkovi&#263;</surname><given-names>D</given-names></string-name>. <article-title>Low cigarette consumption and risk of coronary heart disease and stroke: meta&#8208;analysis of 141 cohort studies in 55 study reports</article-title>. <source>BMJ</source>. <year>2018</year>;<volume>360</volume>:<elocation-id>j5855</elocation-id>. doi: <pub-id pub-id-type="doi">10.1136/bmj.j5855</pub-id><pub-id pub-id-type="pmid">29367388</pub-id><pub-id pub-id-type="pmcid">PMC5781309</pub-id></mixed-citation></ref><ref id="jah38661-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah38661-cit-0019"><string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>. <article-title>Trends in smoking prevalence and implication for chronic diseases in China: serial national cross&#8208;sectional surveys from 2003 to 2013</article-title>. <source>Lancet Respir Med</source>. <year>2019</year>;<volume>7</volume>:<fpage>35</fpage>&#8211;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2213-2600(18)30432-6</pub-id><pub-id pub-id-type="pmid">30482646</pub-id></mixed-citation></ref><ref id="jah38661-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah38661-cit-0020"><string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Masoudi</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Spertus</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Krumholz</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>L</given-names></string-name>. <article-title>ST&#8208;segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE&#8208;Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data</article-title>. <source>Lancet</source>. <year>2015</year>;<volume>385</volume>:<fpage>441</fpage>&#8211;<lpage>451</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60921-1</pub-id><pub-id pub-id-type="pmid">24969506</pub-id><pub-id pub-id-type="pmcid">PMC4415374</pub-id></mixed-citation></ref><ref id="jah38661-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah38661-cit-0021"><string-name name-style="western"><surname>Wang</surname><given-names>HK</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JT</given-names></string-name>, et al. <article-title>Smoking paradox in stroke survivors?: uncovering the truth by interpreting 2 sets of data</article-title>. <source>Stroke</source>. <year>2020</year>;<volume>51</volume>:<fpage>1248</fpage>&#8211;<lpage>1256</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027012</pub-id><pub-id pub-id-type="pmid">32151234</pub-id></mixed-citation></ref><ref id="jah38661-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah38661-cit-0022"><string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gall</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Dewey</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Macdonell</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Sturm</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Thrift</surname><given-names>AG</given-names></string-name>. <article-title>Baseline smoking status and the long&#8208;term risk of death or nonfatal vascular event in people with stroke: a 10&#8208;year survival analysis</article-title>. <source>Stroke</source>. <year>2012</year>;<volume>43</volume>:<fpage>3173</fpage>&#8211;<lpage>3178</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.112.668905</pub-id><pub-id pub-id-type="pmid">23103491</pub-id></mixed-citation></ref><ref id="jah38661-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah38661-cit-0023"><string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ovbiagele</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, et al. <article-title>Clopidogrel and ischemic stroke outcomes by smoking status: smoker's paradox?</article-title><source>J Neurol Sci</source>. <year>2017</year>;<volume>373</volume>:<fpage>41</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jns.2016.12.025</pub-id><pub-id pub-id-type="pmid">28131222</pub-id><pub-id pub-id-type="pmcid">PMC5800495</pub-id></mixed-citation></ref><ref id="jah38661-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah38661-cit-0024"><string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lindley</surname><given-names>RI</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Lavados</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Delcourt</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Arima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ovbiagele</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></string-name>, et al. <article-title>Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study</article-title>. <source>Stroke Vasc Neurol</source>. <year>2021</year>;<volume>6</volume>:<fpage>395</fpage>&#8211;<lpage>401</lpage>. doi: <pub-id pub-id-type="doi">10.1136/svn-2020-000493</pub-id><pub-id pub-id-type="pmid">33526633</pub-id><pub-id pub-id-type="pmcid">PMC8485230</pub-id></mixed-citation></ref><ref id="jah38661-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah38661-cit-0025"><string-name name-style="western"><surname>Zhou</surname><given-names>BF</given-names></string-name>. <article-title>Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults&#8212;study on optimal cut&#8208;off points of body mass index and waist circumference in Chinese adults</article-title>. <source>Biomed Environ Sci</source>. <year>2002</year>;<volume>15</volume>:<fpage>83</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">12046553</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>